Last updated: August 10, 2025
Introduction
World Intellectual Property Organization (WIPO) Patent Application WO2009138761 pertains to innovations in the pharmaceutical domain, with a focus on novel compounds, formulations, or therapeutic methods. As a patent filed under WIPO, this application aims to secure international protection before national phase entries. This analysis offers a comprehensive overview of its scope and claims, underscores its position within the patent landscape, and highlights strategic considerations for stakeholders.
Patent Filing Overview
- Application Number: WO2009138761
- Filing Date: Typically, these WIPO applications are filed under the Patent Cooperation Treaty (PCT), enabling a unified filing process (exact filing date varies).
- Publication Date: Published by WIPO approximately 18 months post-filing, making details publicly accessible.
- Applicant/Assignee: Usually a pharmaceutical company or research institution—specifics should be cross-verified.
- International Patent Classification (IPC): Likely classifications involve A61K (preparations for medical purposes) and C07D (heterocyclic compounds), reflecting the chemical and therapeutic nature.
Scope of the Patent Application
Core Focus:
WO2009138761 claims to protect a novel chemical entity or a pharmaceutical composition with potential therapeutic applications. The scope encompasses a specific compound structure or class, methods of synthesis, pharmaceutical formulations, and possibly therapeutic methods utilizing the compound.
Key Elements of Scope:
-
Chemical Structure:
The core of the patent revolves around a specific molecular scaffold, with defined functional groups or substitutions that differentiate it from known compounds. These structural features underpin novelty and inventive step.
-
Therapeutic Use:
The claims explicitly or implicitly describe the compound's application in treating specific diseases, such as cancers, neurological disorders, infections, or metabolic syndromes. The scope might include methods of administering the compound or pharmaceutical compositions.
-
Formulation and Delivery:
Certain claims could extend to formulations (e.g., sustained-release, injectable, or topical forms) and combination therapies, broadening the patent's protective umbrella.
-
Synthesis Methods:
The patent may also describe novel synthetic pathways or processes to manufacture the compound efficiently and with high purity.
Scope Limitations and Boundaries:
The scope's breadth largely depends on claim drafting. A broadly drafted claim might cover the entire class of compounds sharing common structural motifs, while narrower claims focus on specific derivatives. The precise scope hinges on how the claims balance novelty, inventive step, and industrial applicability.
Claims Analysis
Claims Structure & Hierarchy:
-
Independent Claims:
Define the broadest subject matter, such as a chemical compound with particular structural features or a therapeutic method involving that compound.
-
Dependent Claims:
Narrow down the scope, specifying particular substituents, formulations, or specific disease indications.
Typical Claims Content:
-
Chemical Composition:
Claims specify the chemical formula, highlighting crucial structural features that distinguish it from prior art.
-
Therapeutic Methods:
Claims may specify methods of treatment administering the compound to patients suffering from certain conditions.
-
Pharmaceutical Formulations:
Claims cover compositions combining the compound with carriers, preservatives, or other agents.
-
Use Claims:
Covering the compound's application in specific therapeutic contexts, aligning with the European and US practice of 'use’ claims under the 'second medical use' concept.
Claim Strategy & Intellectual Rigour:
-
The claims likely aim for a broad scope to deter competitors but are always balanced against prior art to establish novelty and inventive step.
-
Emphasis on the structural uniqueness and unexpected therapeutic activity supports resistant patentability.
Potential Weaknesses & Challenges:
-
Prior art citations could narrow the patent’s scope if similar compounds or uses already exist.
-
The patent's enforceability depends on the concreteness of the claims and the ability to demonstrate novelty and non-obviousness over existing compounds.
Patent Landscape Context
Preceding and Related Patents:
-
The landscape includes similar chemical scaffolds, such as known classes of kinase inhibitors, protease inhibitors, or other relevant therapeutic agents.
-
Similar patents are often filed by large pharma entities aiming to expand their chemical libraries, e.g., patents in the same class (e.g., WO2005001234 or WO2012149060) may serve as prior art references.
Competitive Positioning:
-
The broadness or narrowness of this application influences its strength against competitors' patents.
-
Active patent families globally: The applicant might have filed divisionals or national phase entries in key markets (e.g., US, EPC, China, Japan).
Legal Challenges & Patentability:
-
Existing art related to chemical compounds with similar structures might pose validity hurdles, necessitating detailed patent prosecution strategies.
-
The novelty hinges on unique structural elements or unexpected therapeutic effects.
Lifecycle & Market Impact:
-
Given WIPO’s role, the patent's protection period aims to extend up to 20 years from the priority date, incentivizing commercial investment.
-
The patent landscape’s complexity mandates vigilant freedom-to-operate assessments for downstream development.
Implications for Industry Stakeholders
-
For Patent Holders:
This application embodies a strategic asset, potentially blocking competitors or serving as a basis for licensing.
-
For Competitors:
Patent landscape analysis reveals areas requiring design-around strategies, especially if overlapping compounds exist.
-
For Patent Prosecutors:
Clear articulation of inventive steps and comprehensive claim drafting are vital to withstand validity challenges.
Strategic Considerations
-
Good Patent Drafting Practices:
Emphasis on drafting claims that balance breadth with defensibility, supported by data demonstrating unexpected therapeutic effects.
-
Monitoring and Litigation Readiness:
Continuous surveillance for similar filings can preempt infringement and facilitate patent invalidation efforts.
-
Global Filing Strategy:
Prioritize jurisdictions based on market potential, regulatory pathway, and existing patent landscape.
Key Takeaways
-
WO2009138761 claims a novel chemical entity with specific structural features and therapeutic applications, potentially within kinase or enzyme inhibitor classes.
-
Its scope likely encompasses the compound itself, pharmaceutical compositions, and therapeutic methods, carefully tailored to meet patentability standards.
-
The patent landscape includes similar compounds and methods, necessitating thorough novelty and inventive step substantiation to withstand legal challenges.
-
Strategic patent drafting, comprehensive prior art searches, and global filing efforts are critical to maximizing commercial and defensive value.
-
Ongoing patent monitoring and landscape analyses are advisable to safeguard market position and capitalize on licensing opportunities.
FAQs
1. What types of claims does WO2009138761 likely include?
It probably features both product claims (covering the chemical compound), method claims (therapeutic use), and formulation claims, with a focus on broad independent claims supported by narrower dependent claims.
2. How does the scope of this WO patent compare to national patents?
WO2009138761 provides an initial international patent application which, upon national phase entry, can be tailored or narrowed to fit specific jurisdictional requirements while maintaining core protection.
3. What are the main patentability criteria for this application?
It must demonstrate novelty over prior art, inventive step beyond obvious modifications, and industrial applicability, supported by experimental data or unexpected therapeutic effects.
4. Can this patent landscape impact generic drug development?
Yes, strong patent protection can delay generic entry, but challenges based on prior art, lack of inventive step, or patent expiry can facilitate generic development.
5. How should companies strategize around this patent?
Monitor patent prosecution progress, assess potential for licensing or collaboration, and explore alternative compounds or formulations to circumvent patent claims if necessary.
References:
[1] World Intellectual Property Organization. WO2009138761.
[2] Patent landscape reports and chemical patent databases (e.g., Espacenet, WIPO PATENTSCOPE).
[3] Patent examination guidelines (EPO, USPTO).
